Bespoke’s Morning Lineup – 2/20/25 – High Expectations
See what’s driving market performance around the world in today’s Morning Lineup. Bespoke’s Morning Lineup is the best way to start your trading day. Read it now by starting a two-week trial to Bespoke Premium. CLICK HERE to learn more and start your trial.
“High expectations are the key to everything.” – Sam Walton
Below is a snippet of commentary from today’s Morning Lineup. Start a two-week trial to Bespoke Premium to view the full report.
Walmart (WMT) marked the unofficial end to earnings season this morning by reporting slightly better than expected earnings on inline revenues. The company also lowered guidance for Q1 and the full year. As a result of the lowered guidance, the stock is getting pummeled in the pre-market and is on pace to gap down close to 9%. For many high-growth stocks, a 9% gap down in reaction to earnings may not sound extreme, but WMT has historically been a much less volatile stock. Since 2001, its average one-day move in reaction to earnings has been 2.9%, so if current levels hold through the end of the trading day, today’s move would be more than triple its historical average move.
The table below shows prior earnings reports since 2001 when WMT gapped down by at least 5%. It’s only happened five other times, and it has never gapped down more than 8%, so that would put today’s downside gap on pace to be the most negative gap opening in reaction to earnings since at least 2001. As Sam Walton’s quote above says, high expectations are the key to everything, and when a stock like WMT heads into an earnings report trading for over 37 times earnings and lowers guidance, reactions like this aren’t surprising.
For the broader market this morning, S&P 500 futures indicate a decline of about 0.3% at the open and trade near their lows of the day. Today’s weakness, however, comes just hours after the S&P 500 closed at an all-time high yesterday – its third record closing high of the year. The market doesn’t look like it’s done much since its high in December, but YTD, the S&P 500 has managed a rally of over 4%. We’ve seen some weak housing-related data this week, but today’s economic focus will shift to jobless claims and the Philly Fed at 8:30 and leading indicators at 10 AM. Also on the calendar, we’ll hear from various Fed officials throughout the day, starting with Chicago Fed President Goolsbee just after the opening bell.
The Triple Play Report — 2/19/25
An earnings triple play is a stock that reports earnings and manages to 1) beat analyst EPS estimates, 2) beat analyst sales estimates, and 3) raise forward guidance. You can read more about “triple plays” at Investopedia.com where they’ve given Bespoke credit for popularizing the term. We like triple plays as an indication that a company’s business is firing on all cylinders, with better-than-expected results and an improving outlook. A triple play is indicative of positive “fundamental momentum” instead of pure fundamentals, and there are always plenty of names with both high and low valuations on our quarterly list.
Bespoke’s Triple Play Report highlights companies that have recently reported earnings triple plays, and it features commentary from management on triple-play conference calls, company descriptions and analysis, and price charts. Bespoke’s Triple Play Report is available at the Bespoke Institutional level only. You can sign up for Bespoke Institutional now and receive a 14-day trial to read this week’s Triple Play Report, which features 30 new stocks. To sign up, choose either the monthly or annual checkout link below:
Bespoke Institutional – Monthly Payment Plan
Bespoke Institutional – Annual Payment Plan
Doximity (DOCS) is an example of a company that recently reported an earnings triple play; its third in a row. The stock was up a staggering 36% the following day (2/7), which comes after very impressive earnings-day reactions last November (+34.2%), August (+38.7%), and May (+18.1%). Since last May’s report in which the company beat estimates but kept guidance inline, DOCS has climbed roughly 250%.
Here’s how AI describes the company: Doximity has emerged as a leading digital platform dedicated to empowering healthcare professionals. By providing a secure, feature-rich environment for physicians and other clinicians, Doximity enables seamless networking, collaboration, and communication among those in the healthcare space. Its innovative telehealth solutions, streamlined physician workflow tools, and personalized medical news feed have garnered widespread adoption, while its robust advertising and recruiting channels have opened new revenue opportunities. As the healthcare industry continues to embrace digital transformation, Doximity is well-positioned to capitalize on this momentum, paving the way for ongoing growth and a stronger presence in the rapidly evolving health tech landscape.
On its most recent earnings report, growth was fueled by top pharma clients (122% net retention), soaring AI adoption (1.8M prompts, +60% QoQ), and expanding workflow tools (610K+ active prescribers). New point-of-care and formulary products doubled YoY, now making up 20% of pharma sales, while multi-module campaigns drove larger deal sizes. The company’s client portal, now used by 50% of brand clients, is scaling further with 10 new agency partners.
Looking at the snapshot below from our Earnings Explorer, Doximity results have been very consistent against estimates since 2022. The stock has beaten both EPS and revenue estimates for 13 straight quarters, and it has raised guidance on each of its last three reports.
You can read more about DOCS and the 29 other triple plays we covered in our newest report by starting a Bespoke Institutional trial today.
Bespoke Investment Group, LLC believes all information contained in these reports to be accurate, but we do not guarantee its accuracy. None of the information in these reports or any opinions expressed constitutes a solicitation of the purchase or sale of any securities or commodities. This is not personalized advice. Investors should do their own research and/or work with an investment professional when making portfolio decisions. As always, past performance of any investment is not a guarantee of future results. Bespoke representatives or clients may have positions in securities discussed or mentioned in its published content.
Bespoke Baskets Update — February 2025
The Closer – Minutes, GSE Privatization, ADP Megacaps – 2/19/25
Log-in here if you’re a member with access to the Closer.
Looking for deeper insight into markets? In tonight’s Closer sent to Bespoke Institutional clients, we start with commentary regarding today’s Fed Minutes (page 1). Next, we dive into fixed income markets including a look at mortgage rates and a deeper dive into the topic of privatization of GSEs (pages 2 and 3). We then review the latest earnings and residential construction figures (page 4) before providing an updated look at a basket of international mega-cap stocks (page 5). We finish with a rundown of today’s 20-year bond auction(page 6).
See today’s full post-market Closer and everything else Bespoke publishes by starting a 14-day trial to Bespoke Institutional today!
Daily Sector Snapshot — 2/19/25
Chart of the Day: Sectors Since the Pre-COVID High
Bespoke’s Morning Lineup – 2/19/25 – Downside Bias
See what’s driving market performance around the world in today’s Morning Lineup. Bespoke’s Morning Lineup is the best way to start your trading day. Read it now by starting a two-week trial to Bespoke Premium. CLICK HERE to learn more and start your trial.
“There are no rules here — we’re trying to accomplish something.” – Thomas Edison
Below is a snippet of commentary from today’s Morning Lineup. Start a two-week trial to Bespoke Premium to view the full report.
Asian stocks had a mixed showing overnight with Japan down fractionally, and China’s Shanghai Composite rising by 0.8%. Economic data in the region, though, was weak with Home Prices in China falling 5.0% y/y in January versus a decline of 5.3% in December. In Japan, Core Machinery Orders fell 1.2% on a m/m basis which was well below the forecast of an increase of 0.4%.
In Europe, stocks are trading down for a change as the STOXX 600 is down by over 0.5%. Contributing to the weakness there are both micro and macro factors. On the micro side, a weaker-than-expected earnings report from Philips, where sales came in weaker than expected and guidance was weak, has that stock trading down over 10%. On the macro side, UK inflation for January came in at 3%, which was above the consensus forecast of 2.8%. Core inflation, meanwhile, surged up to 3.7% from 3.2% in December.
Here, futures are modestly lower ahead of Building Permits and Housing Starts at 8:30 and FOMC Minutes at 2 PM. Treasury yields, crude oil, and gold are all higher on the day, reversing some of the losses from late last week while Bitcoin has bounced back over 2% to get back above $96K.
With a dozen eggs becoming as popular as a Furby circa Christmas 1998 and what seems like half a paycheck going to fund your daily bacon, egg, and cheese habit, egg prices have become a national nightmare. In last week’s CPI report, egg prices rose over 15% in January representing the largest monthly increase since June 2015. The chart of egg prices makes it look more like the Palantir (PLTR) of the CPI report than a boring old breakfast staple.
Egg prices have caused a frenzy online as Google searches have spiked. The chart below shows Google Trends results for eggs going back to 2004. At first glance, it doesn’t look like the spike has been all that extreme. Searches tend to have a seasonal aspect, but there have been many months in the last ten years when the frequency of searches was higher.
Taking seasonality into account, though, searches are easily at extremes. The chart below is the same as the one above, except that we have included red dots for February of each year. Comparing these February readings, searches have been 30% higher this February than any other February in history. The spikes you see in the chart come every year in either March or April coinciding with Easter. If the recent trends in egg prices continue, we can only imagine what the chart above will look like in two months when Easter arrives.
A headline last week from animal health care company Zoetis (ZTS) provides some hope, though. On Friday, the company announced that it had received conditional approval for a bird flu vaccine from the USDA for use in chickens. While the stock of ZTS saw little reaction, the stock of Cal-Maine Foods (CALM), the largest producer of eggs in the US, has been shelled. CALM has been a big winner from the bird flu, more than doubling in the year leading up to last Friday, but it has declined more than 16% in the last two sessions for its largest two-day decline since December 2022.
Markets are forward-looking, so is CALM’s decline the canary in the coalmine signaling that the worst of this wave of bird flu is behind us? Who knows, maybe by the summer, we’ll be able to afford two eggs on our beacon, egg, and cheese, or maybe even an omelet! Seriously, though, since the recent low in egg prices in September 2023, total CPI is up 3.8%. With egg prices up 63% over that same span and having a weighting of 0.172% in the total CPI index, ex eggs prices, total CPI would be up 9 basis points less at 3.72%. So, in terms of a direct impact, egg prices haven’t had a major impact on inflation over the last 16 months. They haven’t helped, though!
The Closer – Deutschland Breakout, Best of Breed – 2/18/25
Log-in here if you’re a member with access to the Closer.
Looking for deeper insight into markets? In tonight’s Closer sent to Bespoke Institutional clients, we lead off with a look at the performance of German equities relative to the US (pages 1 and 2) followed by an update of our Best of Breed basket (pages 3 and 4). We then review the latest earnings (page 5), preview this week’s Treasury auctions (page 6), and close out with an overview on positioning data (pages 7-10).
See today’s full post-market Closer and everything else Bespoke publishes by starting a 14-day trial to Bespoke Institutional today!